Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 57184 entries
Sorted by: Best Match Show Resources per page
Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease-Reply.

JAMA cardiology

Nestelberger T, Boeddinghaus J, Mueller C.
PMID: 34705018
JAMA Cardiol. 2022 Jan 01;7(1):113-114. doi: 10.1001/jamacardio.2021.4395.

No abstract available.

Cite
Nestelberger T, Boeddinghaus J, Mueller C. Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease-Reply. JAMA Cardiol. 2022;7(1):113-114doi: 10.1001/jamacardio.2021.4395.
Nestelberger, T., Boeddinghaus, J., & Mueller, C. (2022). Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease-Reply. JAMA cardiology, 7(1), 113-114. https://doi.org/10.1001/jamacardio.2021.4395
Nestelberger, Thomas, et al. "Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease-Reply." JAMA cardiology vol. 7,1 (2022): 113-114. doi: https://doi.org/10.1001/jamacardio.2021.4395
Nestelberger T, Boeddinghaus J, Mueller C. Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease-Reply. JAMA Cardiol. 2022 Jan 01;7(1):113-114. doi: 10.1001/jamacardio.2021.4395. PMID: 34705018.
Copy Download .nbib Format: NLM
Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease.

JAMA cardiology

Hayek A, Derimay F, Bochaton T.
PMID: 34705019
JAMA Cardiol. 2022 Jan 01;7(1):112-113. doi: 10.1001/jamacardio.2021.4398.

No abstract available.

Cite
Hayek A, Derimay F, Bochaton T. Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease. JAMA Cardiol. 2022;7(1):112-113doi: 10.1001/jamacardio.2021.4398.
Hayek, A., Derimay, F., & Bochaton, T. (2022). Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease. JAMA cardiology, 7(1), 112-113. https://doi.org/10.1001/jamacardio.2021.4398
Hayek, Ahmad, et al. "Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease." JAMA cardiology vol. 7,1 (2022): 112-113. doi: https://doi.org/10.1001/jamacardio.2021.4398
Hayek A, Derimay F, Bochaton T. Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease. JAMA Cardiol. 2022 Jan 01;7(1):112-113. doi: 10.1001/jamacardio.2021.4398. PMID: 34705019.
Copy Download .nbib Format: NLM
A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers.

Cancer treatment and research communications

Nikoobakht M, Shamshiripour P, Shahin M, Bouzari B, Razavi-Hashemi M, Ahmadvand D, Akbarpour M.
PMID: 34923387
Cancer Treat Res Commun. 2021 Nov 24;30:100490. doi: 10.1016/j.ctarc.2021.100490. Epub 2021 Nov 24.

Brain gliomas are major neurosurgical challenges due to high mortality and morbidity. Hence, development of novel biomarkers is of great value to plan appropriate treatment strategy. Evaluation of the molecular content of extracellular vesicles (EVs) as novel non-invasive biomarker...

Cite
Nikoobakht M, Shamshiripour P, Shahin M, et al. A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers. Cancer Treat Res Commun. 2021;30:100490doi: 10.1016/j.ctarc.2021.100490.
Nikoobakht, M., Shamshiripour, P., Shahin, M., Bouzari, B., Razavi-Hashemi, M., Ahmadvand, D., & Akbarpour, M. (2021). A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers. Cancer treatment and research communications, 30100490. https://doi.org/10.1016/j.ctarc.2021.100490
Nikoobakht, Mehdi, et al. "A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers." Cancer treatment and research communications vol. 30 (2021): 100490. doi: https://doi.org/10.1016/j.ctarc.2021.100490
Nikoobakht M, Shamshiripour P, Shahin M, Bouzari B, Razavi-Hashemi M, Ahmadvand D, Akbarpour M. A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers. Cancer Treat Res Commun. 2021 Nov 24;30:100490. doi: 10.1016/j.ctarc.2021.100490. Epub 2021 Nov 24. PMID: 34923387.
Copy Download .nbib Format: NLM
Identification of Hub Genes Associated with Diabetes Mellitus and Tuberculosis Using Bioinformatic Analysis.

International journal of general medicine

Liu S, Ren W, Yu J, Li C, Tang S.
PMID: 34354368
Int J Gen Med. 2021 Jul 30;14:4061-4072. doi: 10.2147/IJGM.S318071. eCollection 2021.

PURPOSE: To investigate the potential pathophysiological association between tuberculosis (TB) and diabetes mellitus (DM) using bioinformatic analyses.PATIENTS AND METHODS: Gene expression datasets for healthy controls (HCs), TB patients, DM patients, TB+DM patients (GSE114192), and metformin-treated cells (GSE102677) were obtained...

Cite
Liu S, Ren W, Yu J, et al. Identification of Hub Genes Associated with Diabetes Mellitus and Tuberculosis Using Bioinformatic Analysis. Int J Gen Med. 2021;14:4061-4072doi: 10.2147/IJGM.S318071.
Liu, S., Ren, W., Yu, J., Li, C., & Tang, S. (2021). Identification of Hub Genes Associated with Diabetes Mellitus and Tuberculosis Using Bioinformatic Analysis. International journal of general medicine, 144061-4072. https://doi.org/10.2147/IJGM.S318071
Liu, Shengsheng, et al. "Identification of Hub Genes Associated with Diabetes Mellitus and Tuberculosis Using Bioinformatic Analysis." International journal of general medicine vol. 14 (2021): 4061-4072. doi: https://doi.org/10.2147/IJGM.S318071
Liu S, Ren W, Yu J, Li C, Tang S. Identification of Hub Genes Associated with Diabetes Mellitus and Tuberculosis Using Bioinformatic Analysis. Int J Gen Med. 2021 Jul 30;14:4061-4072. doi: 10.2147/IJGM.S318071. eCollection 2021. PMID: 34354368; PMCID: PMC8331204.
Copy Download .nbib Format: NLM
Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome.

Journal of pain research

Echeverria-Villalobos M, Mitchell J, Fiorda-Diaz J, Weaver T.
PMID: 34354373
J Pain Res. 2021 Jul 30;14:2337-2345. doi: 10.2147/JPR.S309872. eCollection 2021.

OBJECTIVE: In this narrative review, we reviewed and discussed current literature describing the molecular mechanisms leading to neuroinflammation and its role in the onset and progression of chronic neuropathic lumbar and leg pain in patients with persistent spinal pain...

Cite
Echeverria-Villalobos M, Mitchell J, Fiorda-Diaz J, et al. Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome. J Pain Res. 2021;14:2337-2345doi: 10.2147/JPR.S309872.
Echeverria-Villalobos, M., Mitchell, J., Fiorda-Diaz, J., & Weaver, T. (2021). Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome. Journal of pain research, 142337-2345. https://doi.org/10.2147/JPR.S309872
Echeverria-Villalobos, Marco, et al. "Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome." Journal of pain research vol. 14 (2021): 2337-2345. doi: https://doi.org/10.2147/JPR.S309872
Echeverria-Villalobos M, Mitchell J, Fiorda-Diaz J, Weaver T. Effects of Dorsal Column Spinal Cord Stimulation on Neuroinflammation: Revisiting Molecular Mechanisms and Clinical Outcomes on Chronic Lumbar/Leg Pain and Failed Back Surgery Syndrome. J Pain Res. 2021 Jul 30;14:2337-2345. doi: 10.2147/JPR.S309872. eCollection 2021. PMID: 34354373; PMCID: PMC8331196.
Copy Download .nbib Format: NLM
Diagnostic Sensitivity of Plasma Endothelin-1 for Cerebral Vasospasm After Subarachnoid Hemorrhage, a Multicentre Double-Blind Study.

Journal of intensive care medicine

Bellapart J, Nasrallah F, Winearls J, Lassig-Smith M, Stuart J, Boots R, Winter C, Flaws D, Bulmer A, Jones L, Laupland KB.
PMID: 34898303
J Intensive Care Med. 2021 Dec 13;8850666211056568. doi: 10.1177/08850666211056568. Epub 2021 Dec 13.

The purpose of this study is to establish the diagnostic sensitivity of Endothelin-1 for risk stratification and screening of clinical vasospasm after subarachnoid hemorrhage.This is a multicentre, observational study, correlating daily blood Endothelin-1 with clinical variables. Binary logistic regression...

Cite
Bellapart J, Nasrallah F, Winearls J, et al. Diagnostic Sensitivity of Plasma Endothelin-1 for Cerebral Vasospasm After Subarachnoid Hemorrhage, a Multicentre Double-Blind Study. J Intensive Care Med. 2021;8850666211056568doi: 10.1177/08850666211056568.
Bellapart, J., Nasrallah, F., Winearls, J., Lassig-Smith, M., Stuart, J., Boots, R., Winter, C., Flaws, D., Bulmer, A., Jones, L., & Laupland, K. B. (2021). Diagnostic Sensitivity of Plasma Endothelin-1 for Cerebral Vasospasm After Subarachnoid Hemorrhage, a Multicentre Double-Blind Study. Journal of intensive care medicine, 8850666211056568. https://doi.org/10.1177/08850666211056568
Bellapart, Judith, et al. "Diagnostic Sensitivity of Plasma Endothelin-1 for Cerebral Vasospasm After Subarachnoid Hemorrhage, a Multicentre Double-Blind Study." Journal of intensive care medicine vol. (2021): 8850666211056568. doi: https://doi.org/10.1177/08850666211056568
Bellapart J, Nasrallah F, Winearls J, Lassig-Smith M, Stuart J, Boots R, Winter C, Flaws D, Bulmer A, Jones L, Laupland KB. Diagnostic Sensitivity of Plasma Endothelin-1 for Cerebral Vasospasm After Subarachnoid Hemorrhage, a Multicentre Double-Blind Study. J Intensive Care Med. 2021 Dec 13;8850666211056568. doi: 10.1177/08850666211056568. Epub 2021 Dec 13. PMID: 34898303.
Copy Download .nbib Format: NLM
Temporal patterns of microglial activation in white matter following experimental mild traumatic brain injury: a systematic literature review.

Acta neuropathologica communications

Velayudhan PS, Schwab N, Hazrati LN, Wheeler AL.
PMID: 34924026
Acta Neuropathol Commun. 2021 Dec 19;9(1):197. doi: 10.1186/s40478-021-01297-1.

Mild traumatic brain injuries (mTBIs) are a prevalent form of injury that can result in persistent neurological impairments. Microglial activation has become increasingly recognized as a key process regulating the pathology of white matter in a wide range of...

Cite
Velayudhan PS, Schwab N, Hazrati LN, et al. Temporal patterns of microglial activation in white matter following experimental mild traumatic brain injury: a systematic literature review. Acta Neuropathol Commun. 2021;9(1):197doi: 10.1186/s40478-021-01297-1.
Velayudhan, P. S., Schwab, N., Hazrati, L. N., & Wheeler, A. L. (2021). Temporal patterns of microglial activation in white matter following experimental mild traumatic brain injury: a systematic literature review. Acta neuropathologica communications, 9(1), 197. https://doi.org/10.1186/s40478-021-01297-1
Velayudhan, Prashanth S, et al. "Temporal patterns of microglial activation in white matter following experimental mild traumatic brain injury: a systematic literature review." Acta neuropathologica communications vol. 9,1 (2021): 197. doi: https://doi.org/10.1186/s40478-021-01297-1
Velayudhan PS, Schwab N, Hazrati LN, Wheeler AL. Temporal patterns of microglial activation in white matter following experimental mild traumatic brain injury: a systematic literature review. Acta Neuropathol Commun. 2021 Dec 19;9(1):197. doi: 10.1186/s40478-021-01297-1. PMID: 34924026; PMCID: PMC8684664.
Copy Download .nbib Format: NLM
Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.

Bioengineered

Yang L, Lu P, Yang X, Li K, Chen X, Qu S.
PMID: 34898376
Bioengineered. 2021 Dec 13; doi: 10.1080/21655979.2021.2003925. Epub 2021 Dec 13.

Long non-coding RNAs (lncRNAs) have been demonstrated to fine-tune gene regulations that govern a broad spectrum of oncogenic processes. Nonetheless, our understanding of the roles of lncRNAs and their interactions with miRNAs and mRNAs in HNSCC is still highly...

Cite
Yang L, Lu P, Yang X, et al. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Bioengineered. 2021;doi: 10.1080/21655979.2021.2003925.
Yang, L., Lu, P., Yang, X., Li, K., Chen, X., & Qu, S. (2021). Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Bioengineered, . https://doi.org/10.1080/21655979.2021.2003925
Yang, Liu, et al. "Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks." Bioengineered vol. (2021). doi: https://doi.org/10.1080/21655979.2021.2003925
Yang L, Lu P, Yang X, Li K, Chen X, Qu S. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Bioengineered. 2021 Dec 13; doi: 10.1080/21655979.2021.2003925. Epub 2021 Dec 13. PMID: 34898376.
Copy Download .nbib Format: NLM
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.

JHEP reports : innovation in hepatology

Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C.
PMID: 34381983
JHEP Rep. 2021 Jun 12;3(4):100321. doi: 10.1016/j.jhepr.2021.100321. eCollection 2021 Aug.

BACKGROUND & AIMS: In autoimmune hepatitis (AIH), normal levels of transaminases and IgG define biochemical remission and are considered the best surrogate markers for histological remission. This study assessed whether this also applies to patients with AIH cirrhosis.METHODS: In...

Cite
Laschtowitz A, Zachou K, Lygoura V, et al. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Rep. 2021;3(4):100321doi: 10.1016/j.jhepr.2021.100321.
Laschtowitz, A., Zachou, K., Lygoura, V., Pape, S., Derben, F., Jaeckel, E., Oller-Moreno, S., Weidemann, S., Krech, T., Piecha, F., Schön, G., Liebhoff, A. M., Al Tarrah, M., Heneghan, M., Drenth, J. P. H., Dalekos, G., Taubert, R., Lohse, A. W., & Schramm, C. (2021). Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP reports : innovation in hepatology, 3(4), 100321. https://doi.org/10.1016/j.jhepr.2021.100321
Laschtowitz, Alena, et al. "Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis." JHEP reports : innovation in hepatology vol. 3,4 (2021): 100321. doi: https://doi.org/10.1016/j.jhepr.2021.100321
Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Rep. 2021 Jun 12;3(4):100321. doi: 10.1016/j.jhepr.2021.100321. eCollection 2021 Aug. PMID: 34381983; PMCID: PMC8333110.
Copy Download .nbib Format: NLM
Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review.

Photodiagnosis and photodynamic therapy

Haroon M, Tahir M, Nawaz H, Majeed MI, Al-Saadi AA.
PMID: 34921990
Photodiagnosis Photodyn Ther. 2021 Dec 16;37:102690. doi: 10.1016/j.pdpdt.2021.102690. Epub 2021 Dec 16.

The present review focuses on the diagnosis of prostate cancer using surface enhanced Raman scattering (SERS) spectroscopy. On the basis of literature search, SERS-based analysis for prostate cancer detection of different sample types is reported in the present study....

Cite
Haroon M, Tahir M, Nawaz H, et al. Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review. Photodiagnosis Photodyn Ther. 2021;37:102690doi: 10.1016/j.pdpdt.2021.102690.
Haroon, M., Tahir, M., Nawaz, H., Majeed, M. I., & Al-Saadi, A. A. (2021). Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review. Photodiagnosis and photodynamic therapy, 37102690. https://doi.org/10.1016/j.pdpdt.2021.102690
Haroon, Muhammad, et al. "Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review." Photodiagnosis and photodynamic therapy vol. 37 (2021): 102690. doi: https://doi.org/10.1016/j.pdpdt.2021.102690
Haroon M, Tahir M, Nawaz H, Majeed MI, Al-Saadi AA. Surface-enhanced Raman scattering (SERS) spectroscopy for prostate cancer diagnosis: A review. Photodiagnosis Photodyn Ther. 2021 Dec 16;37:102690. doi: 10.1016/j.pdpdt.2021.102690. Epub 2021 Dec 16. PMID: 34921990.
Copy Download .nbib Format: NLM
Oat β-glucan alleviates DSS-induced colitis .

Food & function

Bai J, Zhao J, Al-Ansi W, Wang J, Xue L, Liu J, Wang Y, Fan M, Qian H, Li Y, Wang L.
PMID: 34382058
Food Funct. 2021 Oct 04;12(19):8976-8993. doi: 10.1039/d1fo01446c.

Ulcerative colitis (UC) is one of the most prevalent inflammatory bowel diseases (IBD) worldwide, while oat β-glucan has been shown to suppress the progress of colitis in UC mice. However, the underlying mechanism of oat β-glucan in ameliorating colitis...

Cite
Bai J, Zhao J, Al-Ansi W, et al. Oat β-glucan alleviates DSS-induced colitis . Food Funct. 2021;12(19):8976-8993doi: 10.1039/d1fo01446c.
Bai, J., Zhao, J., Al-Ansi, W., Wang, J., Xue, L., Liu, J., Wang, Y., Fan, M., Qian, H., Li, Y., & Wang, L. (2021). Oat β-glucan alleviates DSS-induced colitis . Food & function, 12(19), 8976-8993. https://doi.org/10.1039/d1fo01446c
Bai, Junying, et al. "Oat β-glucan alleviates DSS-induced colitis ." Food & function vol. 12,19 (2021): 8976-8993. doi: https://doi.org/10.1039/d1fo01446c
Bai J, Zhao J, Al-Ansi W, Wang J, Xue L, Liu J, Wang Y, Fan M, Qian H, Li Y, Wang L. Oat β-glucan alleviates DSS-induced colitis . Food Funct. 2021 Oct 04;12(19):8976-8993. doi: 10.1039/d1fo01446c. PMID: 34382058.
Copy Download .nbib Format: NLM
Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma.

Pathology international

Yanagiya M, Dawood RIH, Maishi N, Hida Y, Torii C, Annan DA, Kikuchi H, Yanagawa Matsuda A, Kitamura T, Ohiro Y, Shindoh M, Tanaka S, Kitagawa Y, Hida K.
PMID: 33783897
Pathol Int. 2021 Jun;71(6):383-391. doi: 10.1111/pin.13094. Epub 2021 Mar 30.

Oral squamous cell carcinoma (OSCC) impairs functionality and sensuousness resulting in poor quality of life. Biomarkers can predict disease trajectory and lead to effective treatments. Transcriptomics have identified genes that are upregulated in tumor endothelial cells (TECs) compared with...

Cite
Yanagiya M, Dawood RIH, Maishi N, et al. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma. Pathol Int. 2021;71(6):383-391doi: 10.1111/pin.13094.
Yanagiya, M., Dawood, R. I. H., Maishi, N., Hida, Y., Torii, C., Annan, D. A., Kikuchi, H., Yanagawa Matsuda, A., Kitamura, T., Ohiro, Y., Shindoh, M., Tanaka, S., Kitagawa, Y., & Hida, K. (2021). Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma. Pathology international, 71(6), 383-391. https://doi.org/10.1111/pin.13094
Yanagiya, Misa, et al. "Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma." Pathology international vol. 71,6 (2021): 383-391. doi: https://doi.org/10.1111/pin.13094
Yanagiya M, Dawood RIH, Maishi N, Hida Y, Torii C, Annan DA, Kikuchi H, Yanagawa Matsuda A, Kitamura T, Ohiro Y, Shindoh M, Tanaka S, Kitagawa Y, Hida K. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma. Pathol Int. 2021 Jun;71(6):383-391. doi: 10.1111/pin.13094. Epub 2021 Mar 30. PMID: 33783897.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 57184 entries